The role of nitric oxide (NO) in the host response to infection and in cellular signaling is well established. Enzymatic synthesis of NO is catalyzed by the nitric oxide synthases (NOSs), which convert Arg into NO and citrulline using co-substrates O2 and NADPH. Mammalian NOS contains a flavin reductase domain (FAD and FMN) and a catalytic heme oxygenase domain (P450-type heme and tetrahydrobiopterin). Bacterial NOSs, while much less studied, were previously identified as only containing the heme oxygenase domain of the more complex mammalian NOSs. We report here on the characterization of a NOS from Sorangium cellulosum (both fulllength, scNOS, and oxygenase domain, scNOSox). scNOS contains a catalytic, oxygenase domain similar to those found in the mammalian NOS and in other bacteria. Unlike the other bacterial NOSs reported to date, however, this protein contains a fused reductase domain. The scNOS reductase domain is unique for the entire NOS family because it utilizes a 2Fe2S cluster for electron transfer. scNOS catalytically produces NO and citrulline in the presence of either tetrahydrobiopterin or tetrahydrofolate. These results establish a bacterial electron transfer pathway used for biological NO synthesis as well as a unique flexibility in using different tetrahydropterin cofactors for this reaction.
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heme protein ͉ iron-sulfur cluster ͉ reductase ͉ tetrahydrobiopterin ͉ tetrahydrofolate N itric oxide (NO) is recognized as an important signaling molecule as well as a cytotoxin (1) (2) (3) . A number of diseases are intimately tied to improper function of NO in humans (1) (2) (3) . Given the importance of NO to human health, a wealth of studies has been performed to address questions regarding NO synthesis and regulation (4) (5) (6) (7) (8) (9) . Isolation and structural characterization of the proteins responsible for NO synthesis have led to important developments in understanding the molecular processes of NO formation (10) (11) (12) . Three isoforms of nitric oxide synthase (NOS), iNOS, eNOS, and nNOS, have been characterized in mammals. These enzymes contain an oxygenase domain where the catalysis takes place and a reductase domain that is involved in electron transfer (4, 9) . NOS is functional only as a homodimer, and requires the binding of a Ca 2ϩ -calmodulin (CaM) complex for electron transfer between the reductase and oxygenase domains. The reductase domain transfers electrons from NADPH (nicotinamide adenine dinucleotide phosphate) via FAD (flavin adenine dinucleotide) and FMN (flavin mononucleotide) to the P450-type heme in the oxygenase domain (13) . NOS contains an additional reduced pterin cofactor in the oxygenase domain [H 4 B, (6R)-tetrahydro-l-biopterin], which is required for NO formation and is involved in electron transfer processes during catalysis at the heme (14) (15) (16) .
NOS catalyzes the conversion of Arg into NO and citrulline using O 2 and NADPH involving two catalytic steps. In the first reaction, Arg is oxidized to N G -hydroxy-arginine (NHA). Nitric oxide is generated in the second half of the cycle, with the conversion of NHA into citrulline. The N-hydroxylation of Arg is proposed to occur via an oxygen-rebound mechanism analogous to the cytochrome P450-type enzymes (6) . The second reaction, NHA conversion to citrulline and NO, is unique to NOS. While the mechanism is still under debate, one widely accepted proposal involves a tetrahedral intermediate formed via the nucleophilic attack of a Fe III -hydroperoxo species to NHA (17, 18) . In both steps, the tetrahydrobiopterin cofactor is involved in electron transfer (17, 19) .
More recently, bacterial NOSs have been reported (20) (21) (22) (23) (24) (25) . Unlike eukaryotic NOSs, prokaryotic NOSs do not have a reductase domain as a contiguous polypeptide (20, 21) and consequently NO detection has been mostly limited to single turnover experiments (22) . In the case of Bacillus subtilis, exogenous reductases (a combination of flavodoxin and flavodoxin reductase) were added to NOS, leading to NO formation (determined by the formation of an NOS porphyrinFe(III)NO complex and indirectly by nitrite formation) (23) . Furthermore, studies with B. anthracis and B. subtilis which have a gene for a stand-alone oxygenase domain of NOS, indicate that oxygenase domains of bacterial NOSs generate NO by recruitment of intracellular reductases (24, 25) .
Herein we report the characterization of a prokaryotic NOS from Sorangium cellulosum. This bacterial NOS protein (scNOS) is similar to mammalian NOSs, in that it contains both a reductase and an oxygenase domain in the same polypeptide chain. However, scNOS has distinct differences from the eukaryotic counterpart. Unlike mammalian NOSs, scNOS contains an 2Fe2S ferredoxin subdomain that is involved in electron transfer from NAD(P)H (NADH -nicotinamide adenine dinucleotide-or NADPH) to heme. Furthermore, scNOS can use either tetrahydrobiopterin (H 4 B) or tetrahydrofolate (H 4 F) for NO formation, a feature unique to scNOS. Purified samples of the full-length enzyme (scNOS) and its oxygenase domain (scNOSox) were shown to generate NO under catalytic and stoichiometric conditions, respectively. The discovery of scNOS provides evidence that nitric oxide synthases evolved from a common ancestor, a NOS oxygenase domain, to include specialized reductase domains both in prokaryotes and eukaryotes.
tance and spread of NOS-like enzymes. Predicted ORFs from S. cellulosum (26) contain a putative NOS-like oxygenase domain as part of a larger protein that has another domain which shows significant homology to a reductase domain. Further analysis reveals that the gene for scNOS is predicted to have subdomains corresponding to ferredoxin reductase (FNR), an FAD and NAD(P)H binding protein, and bacterioferritin-associated ferredoxin (Bfd), a 2Fe2S cluster binding protein (Fig. 1) . The relative positions of the binding domains for the 2Fe2S cluster, FAD, and NADPH are at the N terminus as shown in Fig. 1 with predicted Fe binding Cys located between amino acid residues 479 and 516. Unlike S. cellulosum, all other currently known prokaryotic NOSs contain only the oxygenase domain (25) . The oxygenase domain of S. cellulosum NOS has significant (over 48%) sequence identity to other bacterial (Fig. S1 ) as well as to mammalian NO synthases. The NOS from S. cellulosum is unique among those from prokaryotes because of the putative reductase domain in the same polypeptide chain. This is similar to mammalian NOS proteins which consist of NADPH, FAD, and FMN binding subdomains. In contrast, scNOS is predicted to contain a 2Fe2S ferredoxin motif, a feature unprecedented for an NOS. Furthermore, the putative reductase domain in scNOS is located at the N terminus while mammalian proteins contain a Cterminal reductase domain.
Cloning, Expression, Purification, and Characterization of scNOS and scNOSox. Constructs for the predicted full-length protein (sc-NOS) and a truncated construct containing the predicted heme domain (scNOSox) were made. The heme domain construct was selected based on alignment with both the mammalian and bacterial NOS proteins (Fig. S1 ). The N terminus of the mammalian protein (the first Ϸ130 amino-acids) is not present in the S. cellulosum sequence. This portion of the mammalian protein is involved in dimerization via a zinc tetrathiolate motif and contains some of the pterin cofactor binding residues. Based on homology to other bacterial NOSs, scNOSox was constructed to start at Ala-801 (S. cellulosum gene numbering) and to include the C terminus of scNOS (363 amino-acids).
The scNOS and scNOSox constructs were cloned into a pET28b vector encoding an N-terminal His 6 -tag with a TEV protease cleavage site and expressed in Tuner (DE3)pLysS cells. scNOS was purified as described in the methods. The final yield of scNOS was 0.4 mg/L. Quantification of cofactors indicates the presence of FAD (0.63 Ϯ 0.02 equiv. relative to the protein concentration determined using a Bradford assay), heme (0.74 Ϯ 0.04 equiv.), and non-heme iron (1.63 Ϯ 0.02 equiv.). The oxygenase domain was purified as described and gave protein (20 mg/L) of purity in excess of 95%. Analytical gel filtration measurements indicate that scNOSox elutes as a monomer and scNOS as a monomer and dimer mixture.
NOS oxygenase domain spectroscopic properties ( Single Turnover Studies of scNOSox. The reactivity of scNOSox with oxygen in the presence of substrates and cofactor was investigated. The iNOS oxygenase domain converts NHA to NO in single turnover experiments (17) . Following a similar protocol, the scNOSox domain was reduced with a molar equivalent of dithionite and incubated with substrate (Arg or NHA) and cofactor (H 4 B, H 4 F, or none). Oxygenated buffer was added to solutions above in Reacti-vials and the headspace was tested for NO presence (Fig. S4) . NO was detected only in the samples containing cofactors. Samples containing H 4 B generate significant amounts of NO, qualitatively similar to the iNOS heme domain under the same conditions. Samples containing H 4 F generate smaller, but detectable amounts of NO.
To further investigate the involvement of the tetrahydropterin cofactors in the reaction, stopped flow experiments were performed. Solutions of reduced scNOSox, substrate (Arg or NHA) and cofactor (H 4 B, H 4 F, or none) were mixed with oxygenated buffer and monitored by electronic absorption spectroscopy (Fig. 2) . The conversion of a species with a Soret peak at approximately 430 nm to a species with a Soret peak at approx- This could be due to amino acid differences between scNOSox and other NOSs, leading to a faster release of NO from the binding pocket (27) .
Overall, the single turnover experiments establish that the heme chemistry in scNOSox is kinetically affected by the presence of either H 4 B or H 4 F. Furthermore, these results establish that the oxygenase domain is capable of forming NO from NHA in the presence of either tetrahydropterin cofactor, but more efficiently with H 4 B. The faster rate of Fe(II)-O 2 to Fe(III) conversion in the presence of H 4 F compared to H 4 B indicates that the rate-determining electron transfer from tetrahydropterin to heme is faster for H 4 F than H 4 B; however, subsequent fast steps involved in NO generation must be more efficient for H 4 B. Overall, these findings indicate that a tetrahydropterin cofactor capable of electron transfer is necessary for NO formation with scNOSox, behavior similar to related NOS oxygenase domains (16) .
Formation of NO with scNOS. Next the role of the reductase domain was investigated using full-length protein, scNOS. Given the prediction of an NAD(P)H binding reductase domain and our studies of scNOSox, the requirements for NO generation were expected to be similar to mammalian NOSs-Arg, O 2 , reducing agent (NADPH), and tetrahydropterin cofactor (H 4 B or H 4 F).
Both NADPH and NADH were tested for ability to provide reducing equivalents and both were found to support NO formation. NO formation required either H 4 B or H 4 F (Fig. S5) .
Next the catalytic activity of scNOS was determined (Fig. S6 ) (28) . SOD and catalase were required presumably because of uncoupling. The rate of NO generation was found to be about 2.5-fold higher in the presence of H 4 B compared to H 4 F. The initial rate of NAD(P)H consumption (Fig. 3A) indicates that there is only a small preference for NADH vs. NADPH. The decay of NAD(P)H shows a significantly higher rate of reducing equivalent consumption compared to NO production. NAD(P)H is consumed both in the presence and the absence of cofactor. Compared to NO production, the presence of cofactor leads to a NAD(P)H consumption that is about seven to eight times faster for H 4 F and about five to six times faster for H 4 B.
To further explore the role of cofactor in catalytic product formation, citrulline was quantified by HPLC (Fig. 3B) . Mirroring the results of the NO formation assays, more citrulline is generated in the presence of H 4 F and H 4 B. Compared to apo-protein, H 4 F increases the amount of citrulline by about 3-fold while H 4 B by about 5-fold. Notably, citrulline forms in the absence of H 4 B or H 4 F, albeit in smaller amounts. This indicates that the protein is still able to perform substrate activation at the heme; the difference however is reflected in the inability to generate NO in the absence of cofactors.
The present experiments establish the ability of scNOS to catalyze the formation of NO. In the presence of H 4 B, the enzyme activity (0.11 mol NO/min mg protein, at 25°C) is about 2.5-fold higher than with H 4 F (0.046 mol NO/min mg protein). Quantification of citrulline formed correlates with these findings. Analysis of uncoupling with the two cofactors points to a similar trend. When adjusting the rates of electron flow [from NAD(P)H to NO], H 4 B is found to be about 30% coupled while H 4 F about 20% coupled (Fig. 3A) . Part of the significant uncoupling observed in these studies may be due to cofactor loss (heme or 2Fe2S cluster). Nevertheless, these results correlate with the findings of the single turnover experiments in that H 4 B leads to more NO production compared to H 4 F. Assuming similar binding of cofactor to scNOS (10-fold increase in concentration was found to only slightly affect rates of NO production), this difference suggests that H 4 B leads to faster and more efficient NO generation. However, the measured differences between the reactivity of scNOS with the two cofactors are not very large and the ability of this enzyme to use both H 4 B and H 4 F for catalytic NO formation is most notable.
Investigation of scNOS Reduction with NADPH by EPR and UV-Vis
Spectroscopy. EPR samples were prepared anaerobically in the presence of H 4 B and Arg. The EPR spectrum in the absence of NADPH (Fig. 4) is indicative of a high spin Fe(III) heme species (14) . The absence of a signal from the 2Fe2S cluster indicates that it is in a S ϭ 0, [Fe 2 S 2 ] 2ϩ state. Separate samples prepared as above were treated with NADPH; this causes a substantial change in the spectrum-disappearance of the high spin hemeFe(III) signal. A new signal, however, is detectable with an axial g tensor [g Ќ ϭ 1.922 (5), g ʈ ϭ 2.019 (5)]. These g values are consistent with a low-spin (S ϭ 1/2) [Fe 2 S 2 ] ϩ cluster (29, 30) . The disappearance of the heme high spin Fe(III) signal upon NADPH addition is consistent with reduction of heme to EPR-silent Fe(II), presumably via the flavin and 2Fe2S cluster. (A) Initial rates of NADPH and NADH consumption (monitored at A340) and of NO synthesis (monitored at A401 using the oxyhemoglobin assay) using reducing equivalents from NADPH and NADH. NO production rate was multiplied by 1.5 to account for the formal utilization of 1.5 NAD(P)H reducing equivalents required for the reaction. (B) Citrulline formation (end point measurement) in the oxyhemoglobin assay of scNOS activity. Experiments were performed in triplicate. Error bars represent standard deviations.
The observation of a signal for the 2Fe2S cluster is indicative of the ability of NADPH to cause the reduction of this cofactor, and also stands as additional proof for a unique electron transfer pathway in scNOS.
UV-vis spectroscopy experiments were performed to complement the EPR findings (Fig. S3) . Arg and H 4 B were added to anaerobic samples containing oxidized protein. UV-vis spectroscopy reveals the presence of high spin Fe(III) heme species. Addition of NADPH, followed by brief purging with CO gas leads to the appearance of a peak at 445 nm (Fig. S3) , indicative of the formation of the heme Fe(II)-CO complex. As with the EPR experiments, the generation of the heme Fe(II)-CO species upon NADPH addition is indicative of a functional electron transfer pathway from the biological electron donor (NADPH) to the heme reaction center.
Mechanistic Implications. The results in this paper highlight some significant differences between scNOS and other NOSs. The observed activities for NO production, coupled with the NOA data for the scNOSox protein, clearly show that scNOS is a competent catalyst for the generation of NO from Arg. This makes scNOS unique among bacterial NOSs since all others require additional proteins to mediate electron transfer to heme. A significant difference from mammalian NOS is the presence of a 2Fe2S cluster. Formally the 2Fe2S cluster replaces the FMN cofactor in the mammalian NOSs. The redox potentials of FMN in nNOS are Ϫ49 mV (ox/sq, oxidized/semiquinone) and Ϫ274 mV (sq/hq, semiquinone/hydroquinone) (31) . In nNOS, FAD has redox potentials of Ϫ232 mV (ox/sq) and Ϫ280 mV (sq/hq) that allow for FMN reduction by FAD. Since in nNOS the heme Fe(II)/Fe(III) potential is Ϫ248 mV (with bound Arg and H 4 B), FMN (hq) can transfer electrons to ferric heme (32) . The redox potential of the 2Fe2S cluster in Bfd is Ϫ254 mV, (33) which matches the sq/hq couple of FMN in nNOS and is well suited for electron transfer from FAD to heme. Notably, the redox potentials of the 2Fe2S and flavin cofactors can vary significantly as a function of protein environment. The lack of an EPR signal for FAD sq upon scNOS reduction with NADPH suggests a situation in which both FAD hq and sq can transfer electrons to oxidized 2Fe2S. A proposed electron transfer pathway is presented in Fig. 5 . FAD is capable of formally accepting two electrons from NAD(P)H and of performing single electron reductions. These processes lead to the reduction of both the 2Fe2S cluster and the heme. An additional NAD(P)H equivalent can re-reduce FAD leading to a protein state in which all cofactors are reduced. It is noteworthy that by AGF scNOS elutes as an apparent monomer and dimer mixture (the retention times deviate from the calculated molecular weight values; however, the two peaks correspond to a doubling in mass and are most consistent with a monomer and dimer). Hence, more complex mechanisms involving electron transfers between the reductase and oxygenase domains within a dimer are possible and remain to be studied.
The reaction at the heme is proposed to occur in a fashion similar to other NOSs (Fig. 6) (16) . The reduced heme binds O 2 . An additional electron transfer combined with protonation activates it for the oxygenation of the substrate. Similar to mammalian NOSs, scNOS requires a tetrahydropterin cofactor for catalytic formation of NO (16, 17) . This requirement points to a general need for a redox active cofactor in close proximity to the heme, where the catalytic chemistry occurs. Unlike mammalian proteins, however, scNOS is capable of using both H 4 B and H 4 F as cofactors for NO production. While H 4 F was used previously in bacterial NOS studies (21, 22) , NO production was directly observed only recently (39) . Bioinformatics analysis of S. cellulosum suggests that it is capable of H 4 B and H 4 F biosynthesis, (34) hence, in principle, it could use either of these cofactors for NO formation. It is noteworthy that compared to H 4 B, H 4 F leads to faster conversion of Fe(II)-O 2 into Fe(III) (scNOSox), but to slower and less efficient NO generation (scNOS and scNOSox). The fundamental reasons behind this behavior may be related to the relative reactivity of the putative H 3 B• and H 3 F• intermediates. These important mechanistic details remain to be elucidated.
Conclusions
scNOS is an example of a catalytically self-sufficient bacterial NOS. The reductase domain of scNOS is unique in the NOS family by containing a 2Fe-2S ferredoxin cluster. This points to a common ancestor for NOSs-the oxygenase domain. Variants of NOS seem to have evolved to include different types of reductase domains or no reductase domains. An additional unusual feature of scNOS is the ability to form NO in the presence of either H 4 F or H 4 B cofactors, providing a unique platform to characterize the efficiency of these two cofactors for generating NO, perhaps leading to insight into the evolution to use H 4 B as the preferred cofactor for NO biosynthesis in mammals. The biological significance of this cofactor flexibility for scNOS is not clear, but it may involve a mechanism to control NO production under different conditions. The role that this NOS plays in S. cellulosum remains to be defined.
Materials and Methods

Materials. See SI Text for details.
Cloning. scNOS cDNA was generated from bacterial artificial chromosomes provided by Prof. Rolf Mü ller (Institute of Pharmaceutical Biotechnology, University of Saarland, Germany) by PCR using the following primers: 5Ј-GAGGAGCATATGGCCCTGCC GAGCACCATG-3Ј and 5Ј-GAGGAGAAGCTTC-TACCCCTTCCGCTCCTTCCAC-3Ј. The scNOSox construct was generated from above bacterial artificial chromosomes by PCR using primers designed to generate NdeI and HindIII cutsites: 5Ј-GAGGAGCATATGGCGC CCGAGGCG-GTG-3Ј, and 5Ј-GAGGAGAAGCTTCTACCCCTTCCGCTCCTTCCAC-3Ј. Various amounts (5-10%) of DMSO were required for efficient PCR. PCR products were digested with NdeI and HindIII. The genes for scNOS and scNOSox were ligated into the NdeI and HindIII sites of a pET28b vector engineered with a His6-tag and a TEV cleavage site at the 5Ј-end to generate plasmids pET28b-scNOS and pET28b-scNOSox. All genetic manipulations were performed using E. coli DH5a cells. Purified plasmid DNA and PCR products were sequenced by Elim Biopharmaceuticals Inc. to confirm the absence of mutations.
Protein Expression and Purification. For expression, plasmids containing the desired genes were transformed into Tuner (DE3)pLysS cells. Overnight cultures of Tuner (DE3)pLysS-pET28scNOS were used to inoculate (1/100) expression cultures (1 L of Terrific Broth containing 30 mg/L of kanamycin and chloramphenicol, ultra-yield flasks) at 37°C. Upon reaching an A600 of 0.8, the cultures were cooled to 25°C and induced by the addition of isopropyl-beta-D-thiogalactopyranoside (IPTG, 0.4 mM final concentration), and harvested by centrifugation 20 -22 h after induction.
scNOS. Cell pellets from 9 L of culture were resuspended in lysis buffer (50 mM sodium phosphate, pH 8.0, 10 mM imidazole, 10% glycerol, 10 mg/L benzamidine, 5 mg/L leupeptin, and 1 mg/L each of pepstatin, chymostatin, and antipain, and 1 mM pefabloc) to a total volume of 200 mL and lysed using an Emulsiflex-C5 high-pressure homogenizer. Supernatant was prepared by centrifugation for 1 h at 40,000 ϫ g and was loaded by gravity on a 10 mL nickel column (Ni-NTA superflow from QIAGEN). The column was washed with five column volumes (5 ϫ 10 mL) of washing buffer (50 mM sodium phosphate, pH 8.0, 10 mM imidazole). The protein was eluted with 12 mL elution buffer (50 mM sodium phosphate, pH 8.0, 250 mM imidazole). The Ni column was re-equilibrated with washing buffer and the flow through was loaded on the column a second time and washed with five column volumes (5 ϫ 10 mL) of washing buffer, followed by elution with elution buffer. Both elution batches were purified by anion exchange using an HQ8 column and buffer containing 20 mM Tris-HCl, pH 8.0 and 20 mM Tris-HCl, 1 M NaCl, pH 8.0. The scNOS fractions (SDS/PAGE with Coomassie staining) were pooled and concentrated using spin-concentrators with a 50 kDa molecular weight cutoff. Concentrated samples were diluted with TEV protease cleavage buffer (50 mM Tris-HCl, 0.5 mM EDTA, 1 mM DTT, 2 mM imidazole, pH 8), a stock solution of TEV protease was added, followed by incubation at 4°C for 6 -8 h. The buffer was exchanged to washing buffer in three concentration/dilution (higher than 10-fold) cycles. The resulting mixture was loaded on a Ni column and washed with three column volumes (3 ϫ 10 mL) of washing buffer. The flow through was concentrated and buffer exchanged into HEPES (100 mM, pH 7.4), diluted to 20% glycerol concentrated, divided in small aliquots and stored at Ϫ80°C. Protein obtained by this procedure is Ͼ95% pure (SDS/PAGE with Coomassie staining) (Fig. S7) . Total protein concentration (7.1 mg/mL in first batch and 4.6 mg/mL in second batch for a total average of 1.3 mg/L of culture) was determined using the Bradford assay, against a BSA standard curve, and was corroborated with UV-vis spectroscopy of the heme-imidazole complex. MALDI of a trypsin in-gel digested sample confirmed this protein's identity (Ͼ50% coverage). Quantification of FAD, FMN, and heme cofactors was performed by HPLC with calibration against standard curves of commercial samples (17, 35) . Non-heme iron content was determined using a spectrophotometric assay using ferene as a chelator (36) .
scNOSox. Supernatant was prepared as above and loaded on a nickel column (Ni-NTA superflow from QIAGEN) and washed with five column volumes of washing buffer (50 mM sodium phosphate, pH 8.0, 40 mM imidazole), then eluted with elution buffer as above. The wash fraction was rerun through a nickel column, washed, and eluted. The eluate was purified by anion exchange using an HQ8 column, as for scNOS. Fractions containing iNOSheme were red in color and were pooled on the basis of the A280/A429 ratio (ratio of peak Ͻ1.3). Protein obtained (40 mg/L) by this procedure is Ͼ95% pure (SDS/PAGE with Coomassie staining) (Fig. S7 ). The His 6-tag was cleaved using the TEV protease. Quantification of heme cofactor was performed by absorption spectroscopy after protein denaturation and by HPLC (37) . The Fe(III)-imidazole complex was calculated to have 429 ϭ 75 Ϯ 2 mM Ϫ1 cm Ϫ1 by the first method and 429 ϭ 87 Ϯ 1 mM Ϫ1 cm Ϫ1 by the second.
Analytical Gel Filtration. AGF was performed on an Agilent 1200 HPLC system using a mobile phase consisting of 200 mM KH2PO4, 125 mM NaCl, pH 7.4. A calibration curve was generating using the following standards: thyroglobulin (M r ϭ 669 kDa, tr ϭ 8.77 min), yeast alcohol dehydrogenase (150 kDa, 10.58 min), BSA (66 kDa, 10.83 min), ovalbumin (45 kDa, 11.24 min), and cytochrome c (12.4 kDa, 12.03 min). The calculated molecular weight for scNOSox is 41.7 and the protein eluted as a single peak, at 11.1 min (42 kDa). The calculated molecular weight for scNOS is 127 and the protein eluted as two peaks, at 10.66 and 10.19 min (84 and 153 kDa, respectively).
Spectroscopic Assays of scNOS Activity. Initial rate of NO formation was measured by the oxidation of oxyhemoglobin to methemoglobin using extinction coefficient (⌬ 401) of 60,000 M Ϫ1 cm Ϫ1 (28) . A typical 100-L assay contained 500 M substrate (Arg), 6 M oxyhemoglobin, 0, 10, or 100 M H4B (or H 4F), 100 U bovine liver superoxide dismutase, 50 U bovine erythrocyte catalase, 0.5 M scNOS, and 100 M NADPH in 100 mM HEPES, pH 7.4. Reactions were initiated by the addition of NADPH. The H 4B and H4F stock solutions were prepared in DMSO anaerobically. The concentration of the cofactor stocks was determined using 298 of 8.71 mM Ϫ1 cm Ϫ1 and 28 mM Ϫ1 cm Ϫ1 for H4B and H4F, respectively. scNOS stocks were preincubated anaerobically with cofactor (H 4F or H4B) for 45 min before assays. All reactions were run at 25°C for 10 min. Cofactor concentrations of 1 M led to barely detectable levels of NO, 10 M led to reproducible data, and 100 M generated only slight differences compared to 10 M; consequently 10 M was the concentration used for subsequent assays. Similar reaction conditions were used to assay NAD(P)H consumption (at 340 nm, 340 6220 M Ϫ1 cm Ϫ1 ). The linear portion of absorbance (A 401 or A340) vs. time plot (typically 0.2-0.5 min) was used to determine initial rates of NO generation or NAD(P)H consumption, respectively.
Assay of scNOS Activity Using an NO Analyzer. NO formation was detected using an NO analyzer (Sievers model 270). A 40-L final assay mix contained 500 M substrate (Arg), 0 or 10 M H4B (or H4F), 100 U bovine liver superoxide dismutase, 50 U bovine erythrocyte catalase, 0.5 M scNOS, and 100 M NADPH in 100 mM HEPES, pH 7.4. Reactions were initiated with NAD(P)H in oxygenated buffer. All reactions were run at 25°C in sealed Reacti-vials (Pierce). NO formation was determined at 2 and 10 min (200 L of headspace). Citrulline was quantified using HPLC (17) .
Single Turnover Experiments with scNOSox. NO formation was detected using the NO analyzer. A 40-L final assay mix contained 500 M substrate (NHA), 0 or 200 M H4B or 400 M H4F, 20 -60 M scNOSox in 100 mM HEPES, pH 7.4. Reactions were initiated with oxygenated buffer. All reactions were run at 
